MedTrace Logo

A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults

NCT00480155 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2008-12-22

No results posted yet for this study

Summary

To assess the safety of a vaccine in healthy adults prior to the release of the vaccine (FluMist®) containing it.

Conditions

  • Healthy

Interventions

BIOLOGICAL

Frozen FluMist®

Monovalent vaccine is supplied in intranasal sprayers containing 0.5 mL.

OTHER

Placebo

Sponsors & Collaborators

  • MedImmune LLC

    lead INDUSTRY

Principal Investigators

  • Rayburn Mallory, M.D. · MedImmune LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00480155 on ClinicalTrials.gov